NCT03515629 REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer Status TERMINATED Phase PHASE3
NCT03514732 Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorders Status COMPLETED Phase PHASE1
NCT03510884 An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT03510715 An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT03492489 Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma Status NO_LONGER_AVAILABLE Phase N/A
NCT03485677 Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3 Status COMPLETED Phase PHASE3
NCT03463135 A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients Status COMPLETED Phase PHASE1
NCT03462069 Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension Status COMPLETED Phase PHASE2
NCT03462017 Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT03449758 Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT03439943 Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease Status COMPLETED Phase PHASE2
NCT03437720 Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Disease Status WITHDRAWN Phase PHASE2
NCT03436498 Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients Status COMPLETED Phase PHASE1
NCT03434119 Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents Status TERMINATED Phase PHASE3
NCT03430063 A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer Status TERMINATED Phase PHASE2
NCT03428646 Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03415269 A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough. Status COMPLETED Phase PHASE2